A detailed history of First Dallas Securities Inc. transactions in Pfizer Inc stock. As of the latest transaction made, First Dallas Securities Inc. holds 22,600 shares of PFE stock, worth $583,758. This represents 0.28% of its overall portfolio holdings.

Number of Shares
22,600
Previous 25,300 10.67%
Holding current value
$583,758
Previous $707,000 7.5%
% of portfolio
0.28%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$27.7 - $31.39 $74,790 - $84,753
-2,700 Reduced 10.67%
22,600 $654,000
Q2 2024

Aug 02, 2024

BUY
$25.26 - $29.6 $128,826 - $150,960
5,100 Added 25.25%
25,300 $707,000
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $138,511 - $159,055
5,350 Added 36.03%
20,200 $561,000
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $388,030 - $504,008
14,850 New
14,850 $428,000
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $531,060 - $693,240
-12,720 Reduced 57.19%
9,523 $488,000
Q3 2022

Oct 21, 2022

SELL
$43.76 - $53.42 $715,432 - $873,363
-16,349 Reduced 42.36%
22,243 $973,000
Q2 2022

Jul 28, 2022

SELL
$46.53 - $55.17 $524,020 - $621,324
-11,262 Reduced 22.59%
38,592 $2.02 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $5,856 - $7,256
-128 Reduced 0.26%
49,854 $2.58 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $304,239 - $450,983
7,363 Added 17.28%
49,982 $2.95 Million
Q3 2021

Oct 06, 2021

BUY
$39.25 - $50.42 $1.67 Million - $2.15 Million
42,619 New
42,619 $1.83 Million
Q1 2018

May 04, 2018

SELL
$31.91 - $37.02 $104,026 - $120,685
-3,260 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$33.26 - $35.29 $108,427 - $115,045
3,260
3,260 $118,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Dallas Securities Inc. Portfolio

Follow First Dallas Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Dallas Securities Inc. with notifications on news.